PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Vitamin E polyethylene glycol succinate
1Nonproprietary names
- BPTocofersolan
- Ph. Eur.Tocofersolan
- USP–NFVitamin E Polyethylene Glycol Succinate
2Synonyms and trade names
Tocofersolan; TPGS; vitamin E TPGS; d-α-tocopheryl polyethylene glycol 1000 succinate; Kolliphor TPGS
3Chemical name and CAS Registry Number
RRR-α-Tocopheryl polyethylene glycol 1000 succinate · [9002-96-4]
4Empirical formula and molecular weight
C33O5H54(CH2CH2O)n, n ≈ 22 · ≈ 1513
5Functional category
Solubilising agent, Surfactant, emulsifier
Typical concentrations: — · Dosage forms: Liquid
6Applications in pharmaceutical formulation
A non-ionic surfactant used as a solubiliser, emulsifier and absorption enhancer for poorly soluble drugs in oral liquids, lipid-based capsule fills, solid dispersions and self-emulsifying systems. It also inhibits P-glycoprotein efflux, which can improve the oral bioavailability of some drugs, and is used as a water-miscible source of vitamin E for patients with fat malabsorption.
7Description
A white to light brown, waxy solid that is practically odourless and tasteless. It is made of a lipophilic d-α-tocopherol head linked through succinic acid to a hydrophilic polyethylene glycol 1000 chain, and contains small amounts of free tocopherol, tocopheryl succinate and the diester.
8Typical properties
- HLB
- about 13
- Critical micelle concentration
- about 0.02% w/w (in water at 37 °C)
- Melting point
- about 37–41 °C
- Solubility
- soluble in water (forms micellar solutions at up to about 20% w/w; liquid-crystalline phases form at higher concentrations); soluble in ethanol and many lipids
- Physical form
- white to light brown, waxy solid
9Stability and storage conditions
Stable in air but the ester bonds hydrolyse in alkaline conditions, so solutions are best kept below about pH 7. Store in a tightly closed container, protected from light and heat.
10Incompatibilities
Incompatible with strong oxidising agents and strong alkalis.
11Method of manufacture
Prepared by esterifying d-α-tocopheryl acid succinate with polyethylene glycol 1000.
12Safety
Generally well tolerated orally; it is hydrolysed in the gut to release tocopherol. Very large doses may cause diarrhoea. The combination of high TPGS and propylene glycol content in some paediatric oral solutions has raised concern in young children.
13Handling precautions
Observe normal precautions for the quantity handled. Eye protection and gloves are recommended. The waxy solid is usually melted (above about 40 °C) for processing.
14Regulatory status
Included in the FDA Inactive Ingredient Database (oral capsules and solutions) and in medicines licensed in the USA and Europe, including a vitamin E preparation for children with chronic cholestasis.
15Related substances
Alpha tocopherol; polyethylene glycol; polysorbate 80; macrogolglycerol ricinoleate.
16Comments
Because it melts near body temperature, it can be filled as a melt into hard or soft capsules. Its P-glycoprotein inhibition may alter the absorption of co-administered substrates, which should be considered when it is used at high levels.